| Literature DB >> 35652962 |
Enrico Peira1,2, Davide Poggiali3, Matteo Pardini4,5, Henryk Barthel6, Osama Sabri6, Silvia Morbelli5,7, Annachiara Cagnin8, Andrea Chincarini9, Diego Cecchin3,10.
Abstract
PURPOSE: To date, there is no consensus on how to semi-quantitatively assess brain amyloid PET. Some approaches use late acquisition alone (e.g., ELBA, based on radiomic features), others integrate the early scan (e.g., TDr, which targets the area of maximum perfusion) and structural imaging (e.g., WMR, that compares kinetic behaviour of white and grey matter, or SI based on the kinetic characteristics of the grey matter alone). In this study SUVr, ELBA, TDr, WMR, and SI were compared. The latter - the most complete one - provided the reference measure for amyloid burden allowing to assess the efficacy and feasibility in clinical setting of the other approaches.Entities:
Keywords: Age-related amyloid; Amyloid PET; Dual time point; Quantification; Regional amyloid
Mesh:
Substances:
Year: 2022 PMID: 35652962 PMCID: PMC9525368 DOI: 10.1007/s00259-022-05846-1
Source DB: PubMed Journal: Eur J Nucl Med Mol Imaging ISSN: 1619-7070 Impact factor: 10.057
Minimum requirements for each quantifier
| Acquisition | Processing | ||||
|---|---|---|---|---|---|
PET late | PET early | MRI T13D | reference ROI | target ROI | |
| SUVr | • | • | • | ||
| ELBA | • | ||||
| TDr | • | • | |||
| WMR | • | • | • | • | • |
| SI | • | • | • | • | • |
Fig. 1Dispersions of the quantifiers (and of their linear combinations) from SI at the brain and lobar levels. The values reported correspond to the bootstrapped divergences from SI and are expressed as the average σ from the Bland–Altman analysis
Fig. 2Bland–Altman plots of SUVr vs. SI (left), ELBA vs. SI (middle), and AVG1 (weighted mean of SUVr and ELBA) vs. SI (right). The quantifiers are compared in these plots at the whole-brain level. As expected, a combination of two methods (AVG1) reduces the dispersion (red area) of the Bland–Altman plot compared with the single methods
Fig. 3Correlations between the quantifiers (and their linear combinations) and SI at the whole-brain and lobar levels (all correlations significant at p < 0.05)
Fig. 4Regional and whole-brain AUC performance (average over bootstrap sampling) of the quantifiers and their linear combinations vs. visual assessment
Associations between the quantifier scores, age, and cortical thickness at the whole-brain and lobar levels in qualitatively assessed amyloid-negative patients
| Region | Quantifier | Age | Thickness | ||
|---|---|---|---|---|---|
| Whole brain | SUVr | n.s | n.s | ||
| ELBA | n.s | n.s | |||
| TDr | 0.021 | **a | n.s | ||
| WMR | 0.022 | *a | n.s | ||
| SI | 0.020 | **a | 0.724 | * | |
| Frontal right/left | SUVr | n.s./n.s | n.s./n.s | ||
| ELBA | n.s./n.s | n.s./n.s | |||
| TDr | 0.019/0.020 | **a/**a | n.s./n.s | ||
| WMR | 0.017/0.016 | *a/*a | n.s./n.s | ||
| SI | 0.018/0.019 | **a/**a | –/0.698 | n.s./* | |
| Parietal right/left | SUVr | n.s./n.s | n.s./n.s | ||
| ELBA | n.s./n.s | n.s./n.s | |||
| TDr | 0.018/0.020 | *a/**a | n.s./n.s | ||
| WMR | 0.014/0.013 | *a/*a | n.s./n.s | ||
| SI | 0.019/0.019 | **a/** a | n.s./n.s | ||
| Temporal right/left | SUVr | 0.017/– | *a/n.s | 0.859/– | */n.s |
| ELBA | 0.013/– | *a/n.s | 1.010/– | */n.s | |
| TDr | 0.023/0.021 | **a/**a | n.s./n.s | ||
| WMR | 0.028/0.028 | *a/*a | 1.130 / 1.901 | */* | |
| SI | 0.023/0.020 | **a/**a | 0.885 / 0.574 | */* | |
| Occipital right/left | SUVr | n.s./n.s | n.s./n.s | ||
| ELBA | n.s./n.s | n.s./n.s | |||
| TDr | 0.019/0.019 | **a/*a | n.s./n.s | ||
| WMR | –/0.018 | n.s./*a | n.s./n.s | ||
| SI | 0.021/0.026 | **a/**a | n.s./n.s | ||
**p < 0.001, *p < 0.05, n.s. p > 0.05
aStill significant (p < 0.05) after p-value correction for multiple comparisons with the Benjamini–Hochberg procedure for multiple testing
Fig. 5Scatter plot of age vs. whole-brain SI (left) and TDr (right) in the amyloid-negative subset. Both SI and TDr correlated significantly with age (ρ = 0.51 and ρ = 0.48, respectively)
Fig. 6Possible choices of amy-PET semi-quantification approach based on imaging data availability and analysis refinement. T1, MRI 3DT1; Late, late static amy-PET acquisition; Early, early static amy-PET acquisition; Corrected, atrophy-corrected analysis